GO:0072716 response to actinomycin D: Cellular Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072716 (response to actinomycin D) describes any cellular or organismal change triggered by actinomycin D, a DNA-intercalating antibiotic that inhibits transcription and induces nucleolar stress.
• Actinomycin D is widely used experimentally to block RNA polymerase I and II, making it a key tool for studying transcription, ribosome biogenesis, and stress responses.
• The response involves nucleolar stress, p53 activation, and altered gene expression, with GRK5 modifying the nucleolar stress response in mammalian cells.
• In plants, actinomycin D inhibits ribosome biogenesis and affects root development, showing conserved stress pathways.
• Actinomycin D is used clinically in chemotherapy regimens (e.g., DMAC for lymphoma) and can cause drug eruptions like erythema multiforme.
• Primary cortical neurons exposed to actinomycin D show survival and functional recovery, highlighting neuronal stress responses.
Description
Actinomycin D is a well-known antibiotic that intercalates into DNA and inhibits RNA polymerase, leading to a cellular response known as response to actinomycin D (GO:0072716). This biological process encompasses changes in cell state or activity, including gene expression, secretion, and movement, following exposure to the drug. Researchers use actinomycin D as a tool to study transcription, nucleolar stress, and apoptosis, making GO:0072716 a critical term for understanding cellular stress responses. The response is conserved across species, from mammals to plants, and involves complex signaling pathways. In clinical settings, actinomycin D is part of chemotherapy regimens, and its effects on normal tissues can lead to adverse reactions. Thus, studying this response has implications for cancer therapy, neurobiology, and drug safety.
response to actinomycin D At A Glance
| GO ID | GO:0072716 |
|---|---|
| GO term | response to actinomycin D |
| Ontology | biological_process |
| Synonym | none |
| Major function | Cellular response to actinomycin D, including transcription inhibition, nucleolar stress, and apoptosis |
| Definition source | QuickGO |
| Related stimuli | Actinomycin D, a DNA-intercalating antibiotic |
| Key pathways | Nucleolar stress, p53 signaling, ribosome biogenesis inhibition |
What Is GO:0072716?
GO:0072716, response to actinomycin D, is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an actinomycin D stimulus. This includes signaling cascades, transcriptional changes, and metabolic adjustments triggered by the drug.
Why Is response to actinomycin D Important in Cell Biology?
Understanding response to actinomycin D is crucial because actinomycin D is both a chemotherapeutic agent and a research tool. It helps elucidate fundamental processes like transcription, ribosome biogenesis, and stress-induced apoptosis. In cancer, actinomycin D is used in regimens such as DMAC for relapsed lymphoma, and its side effects, including erythema multiforme, are clinically relevant. In neuroscience, actinomycin D studies reveal neuronal survival mechanisms. Moreover, the response is conserved in plants, affecting root development, which has agricultural implications. Thus, GO:0072716 bridges basic cell biology, pharmacology, and disease research.
• Actinomycin D is a standard inhibitor of transcription, used to study RNA synthesis and turnover.
• The response involves nucleolar stress, which is linked to ribosomopathies and cancer.
• GRK5 modifies the nucleolar stress response, highlighting kinase involvement.
• In plants, actinomycin D affects root development by inhibiting ribosome biogenesis.
• Actinomycin D is part of chemotherapy for lymphoma and other cancers.
• Adverse drug reactions like erythema multiforme can occur.
• Primary cortical neurons show survival and recovery after actinomycin D exposure.
• Actinomycin D inhibits HIV reverse transcriptase by binding single-stranded DNA.
• The response is relevant to pituitary hormone regulation in rats.
• Studying this response aids in understanding drug resistance and toxicity.
What Happens During response to actinomycin D?
Actinomycin D Binding and Transcription Inhibition
In simple terms: Actinomycin D sticks to DNA and blocks the enzyme that makes RNA.
Actinomycin D intercalates into DNA at GC-rich sequences, forming a stable complex that inhibits RNA polymerase I and II, thereby blocking transcription. This binding is sequence-specific and can also affect single-stranded DNA, inhibiting polymerases such as HIV reverse transcriptase. The inhibition of transcription leads to a rapid decline in RNA synthesis, triggering downstream stress responses.
Nucleolar Stress and Ribosome Biogenesis Inhibition
In simple terms: When transcription is blocked, the nucleolus gets stressed and ribosome production stops.
Actinomycin D disrupts nucleolar function by inhibiting ribosomal RNA synthesis, causing nucleolar stress. This stress activates pathways that monitor ribosome biogenesis, leading to p53 stabilization and cell cycle arrest. In Arabidopsis, actinomycin D inhibits ribosome biogenesis and affects root development, demonstrating a conserved response.
Signaling Pathways and Gene Expression Changes
In simple terms: The cell turns on stress signals and changes which genes are active.
The response to actinomycin D involves activation of stress kinases and transcription factors. GRK5 modifies the nucleolar stress response, indicating G protein-coupled receptor kinase involvement. Changes in gene expression include upregulation of pro-apoptotic genes and downregulation of survival factors, as seen in primary cortical neurons where survival and functional recovery occur after exposure.
Cellular Outcomes: Apoptosis, Survival, and Recovery
In simple terms: Cells may die, survive, or recover depending on the context.
Actinomycin D can induce apoptosis in cancer cells, but some cells, like primary cortical neurons, can survive and recover function. In chemotherapy, actinomycin D leads to cell death in tumor cells but can also cause adverse reactions such as erythema multiforme. The balance between survival and death depends on cell type and signaling status.
Organismal and Physiological Effects
In simple terms: The drug affects whole organisms, including hormone responses.
In rats, actinomycin D inhibits the pituitary response to LH-RH, and this effect is modulated by oestradiol, indicating that the response can impact endocrine function. In dogs with lymphoma, actinomycin D is part of a multi-drug protocol, showing its systemic effects.
Key Genes Involved in GO:0072716 response to actinomycin D
The following genes and proteins are involved in the response to actinomycin D, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Tumor suppressor, activated by nucleolar stress | Mediates cell cycle arrest and apoptosis in response to actinomycin D |
| GRK5 | G protein-coupled receptor kinase 5, modifies nucleolar stress response | Regulates stress signaling after actinomycin D |
| POLR1A | RNA polymerase I subunit, inhibited by actinomycin D | Target of actinomycin D, affects rRNA synthesis |
| POLR2A | RNA polymerase II subunit, inhibited by actinomycin D | Blocked by actinomycin D, affecting mRNA synthesis |
| NPM1 | Nucleophosmin, nucleolar protein | Relocalizes under nucleolar stress |
| MDM2 | E3 ubiquitin ligase, regulates p53 | Inhibited by nucleolar stress, leading to p53 activation |
| CDKN1A | p21, cell cycle inhibitor | Induced by p53 after actinomycin D |
| BAX | Pro-apoptotic Bcl-2 family member | Upregulated during apoptosis |
| BCL2 | Anti-apoptotic protein | Downregulated in some contexts |
| CASP3 | Caspase 3, executioner of apoptosis | Activated in actinomycin D-induced apoptosis |
| RPL5 | Ribosomal protein L5 | Involved in ribosome biogenesis stress |
| RPL11 | Ribosomal protein L11 | Binds MDM2, activates p53 |
| RPS7 | Ribosomal protein S7 | Involved in nucleolar stress |
| ACTB | Beta-actin, cytoskeletal protein | Used as control in expression studies |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Control for gene expression |
| LH-RH | Luteinizing hormone-releasing hormone | Pituitary response affected by actinomycin D |
| Oestradiol | Steroid hormone | Modulates pituitary response to actinomycin D |
How Is response to actinomycin D Regulated?
The response to actinomycin D is regulated at multiple levels. GRK5 modifies the nucleolar stress response, indicating kinase-dependent regulation. The p53-MDM2 axis is central, with ribosomal proteins like RPL11 and RPS7 inhibiting MDM2 to activate p53. In plants, ribosome biogenesis inhibition affects root development, suggesting developmental regulation. Hormonal factors like oestradiol can modulate the response in pituitary cells.
response to actinomycin D and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer, apoptosis | TP53 knockout cell lines |
| GRK5 | Nucleolar stress response | GRK5 overexpression or knockout cells |
| RPL11 | Ribosomopathy, p53 activation | RPL11 mutant knock-in cells |
| MDM2 | Cancer, p53 regulation | MDM2 point mutation models |
| CASP3 | Apoptosis | CASP3 knockout neurons |
Cancer and Chemotherapy
Actinomycin D is used in chemotherapy regimens such as DMAC for relapsed lymphoma in dogs, and its response pathways influence tumor cell death. In humans, actinomycin D is part of treatment for gestational trophoblastic neoplasia, but can cause erythema multiforme drug eruption. Understanding GO:0072716 may help predict drug efficacy and toxicity.
Neurodegeneration and Neuronal Survival
Primary cortical neurons exposed to actinomycin D can survive and recover function, suggesting that neuronal stress responses may be relevant to neurodegenerative diseases. The mechanisms of recovery could inform neuroprotective strategies.
Ribosomopathies and Nucleolar Stress
Actinomycin D induces nucleolar stress, which is linked to ribosomopathies such as Diamond-Blackfan anemia. Studying this response helps understand how defects in ribosome biogenesis lead to disease.
Viral Infections
Actinomycin D inhibits HIV reverse transcriptase by binding single-stranded DNA, indicating potential antiviral applications and relevance to viral replication studies.
From response to actinomycin D-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TP53 mediate actinomycin D-induced apoptosis? | TP53 knockout cell line |
| How does GRK5 modify nucleolar stress? | GRK5 overexpression and knockout cells |
| What is the role of RPL11 in p53 activation? | RPL11 point mutation knock-in |
| Can neurons recover after actinomycin D? | Primary cortical neuron cultures |
| Does actinomycin D affect root development? | Arabidopsis root model |
| How does actinomycin D inhibit HIV RT? | In vitro polymerase assays |
How to Study the response to actinomycin D Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify p53 targets after actinomycin D |
| Ribo-seq | Translated mRNA profiles | Assess ribosome biogenesis inhibition |
| Proteomics | Protein abundance and modifications | Study GRK5 signaling |
| Immunofluorescence | Protein localization | Nucleolar stress markers |
| Caspase activity assay | Apoptosis | Neuronal survival studies |
| MTT assay | Cell viability | Chemotherapy response |
| qPCR | Specific gene expression | Validate RNA-seq findings |
Transcriptomics and RNA-seq
RNA sequencing can measure global changes in gene expression after actinomycin D treatment, revealing transcriptional responses and alternative splicing. This method is useful for identifying p53 target genes and stress pathways.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify protein abundance and phosphorylation changes, such as GRK5-mediated signaling. This helps identify post-translational modifications in the response.
Imaging and Nucleolar Stress Assays
Fluorescence microscopy can visualize nucleolar disruption and relocalization of proteins like NPM1. Live-cell imaging in neurons can track survival and recovery.
Cell Viability and Apoptosis Assays
MTT, caspase activity, and Annexin V staining measure cell death and survival after actinomycin D exposure. These are standard for evaluating drug response.
How CRISPR Can Be Used to Study GO:0072716 response to actinomycin D
Knockout
CRISPR knockout of genes like TP53 or GRK5 can determine their necessity in the response to actinomycin D. For example, TP53 knockout cells fail to arrest or apoptose after treatment.
Point Mutation
Introducing point mutations in genes such as RPL11 or MDM2 can dissect specific domains required for p53 activation. This helps map signaling interfaces.
Knock-in
Knock-in of tagged versions of proteins like NPM1 allows tracking of localization and interactions during nucleolar stress. This can reveal dynamic changes.
Overexpression
Overexpressing GRK5 or other regulators can test sufficiency in modifying the response. This is useful for gain-of-function studies.
How EDITGENE Supports response to actinomycin D Research
Researchers studying response to actinomycin D-related genes often need to determine whether a candidate gene is causally involved in the stress response, nucleolar stress, or cell survival. EDITGENE provides comprehensive CRISPR services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for response to actinomycin D research.
Frequently Asked Questions About response to actinomycin D
What is GO:0072716?
GO:0072716 is the Gene Ontology term for response to actinomycin D, defined as any process that results in a change in state or activity of a cell or organism as a result of an actinomycin D stimulus.
What genes are involved in response to actinomycin D?
Key genes include TP53, GRK5, POLR1A, POLR2A, NPM1, MDM2, CDKN1A, BAX, BCL2, CASP3, RPL5, RPL11, and RPS7, among others.
How does actinomycin D work?
Actinomycin D intercalates into DNA and inhibits RNA polymerase, blocking transcription and inducing nucleolar stress.
What is the role of p53 in response to actinomycin D?
p53 is activated by nucleolar stress and mediates cell cycle arrest and apoptosis in response to actinomycin D.
Can actinomycin D cause nerve damage?
Primary cortical neurons can survive and recover after actinomycin D exposure, but the drug can induce apoptosis in other cell types.
Is actinomycin D used in cancer treatment?
Yes, actinomycin D is part of chemotherapy regimens such as DMAC for lymphoma and is used in gestational trophoblastic neoplasia.
What are the side effects of actinomycin D?
Side effects can include erythema multiforme drug eruption, as reported in chemotherapy for invasive mole.
How is response to actinomycin D studied?
Methods include RNA-seq, proteomics, imaging, and cell viability assays, often using CRISPR knockout models.
Does actinomycin D affect plants?
Yes, in Arabidopsis, actinomycin D inhibits ribosome biogenesis and affects root development.
What is the connection between actinomycin D and HIV?
Actinomycin D binds single-stranded DNA and inhibits HIV reverse transcriptase, suggesting antiviral potential.
Conclusion
GO:0072716 response to actinomycin D is a critical biological process that integrates transcription inhibition, nucleolar stress, and cell fate decisions. Its study spans cancer therapy, neurobiology, and plant development, with key roles for TP53, GRK5, and ribosomal proteins. Understanding this response can inform drug development and toxicity management. EDITGENE offers advanced CRISPR tools to dissect these pathways and accelerate discovery.
References
- 1. Alvarez FJ et al.. 2006. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.. J Vet Intern Med 20(5):1178-83 PMID: 17063713
- 2. Lee SE et al.. 2022. Survival and functional recovery of primary cortical neurons exposed to actinomycin D.. Biochem Biophys Res Commun 636(Pt 1):132-139 PMID: 36332475
- 3. Wang S et al.. 2022. 5-Fluorouracil and actinomycin D lead to erythema multiforme drug eruption in chemotherapy of invasive mole: Case report and literature review.. Medicine (Baltimore) 101(47):e31678 PMID: 36451432
- 4. Sok V et al.. 2021. G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D.. Biochem Cell Biol 99(4):508-518 PMID: 33507833
- 5. Rettori V et al.. 1976. Effect of actinomycin D on the inhibition of the pituitary response to LH-RH by oestradiol in rats.. J Reprod Fertil 48(1):185-7 PMID: 787520
- 6. Vilchez-Martinez JA et al.. 1976. Effect of actinomycin D on the pituitary response to LH-RH.. Acta Endocrinol (Copenh) 81(1):73-81 PMID: 1108569
- 7. Zhao Y et al.. 2022. Inhibition of ribosome biogenesis by actinomycin D affects Arabidopsis root development.. Biochem Biophys Res Commun 588:61-67 PMID: 34952471
- 8. Rill RL et al.. 1996. Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases.. Biochemistry 35(11):3525-33 PMID: 8639503
